Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan A Oren

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The American Journal of Psychiatry|April 2, 2002
An open trial of morning light therapy for treatment of antepartum depressionDan A Oren, Katherine L Wisner, Margaret Spinelli, et al.
Psychopharmacology|September 6, 2006
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidolRaisa Andrezina, Richard C Josiassen, Ronald N Marcus, et al.
The Journal of Clinical Psychiatry|April 21, 2004
Randomized clinical trial of bright light therapy for antepartum depression: preliminary findingsC Neill Epperson, Michael Terman, Jiuan Su Terman, et al.
Journal of Clinical Pharmacology|July 21, 2006
Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjectsAlbert J Azzaro, Chad M Vandenberg, Lawrence F Blob, et al.
Journal of Photochemistry and Photobiology. B, Biology|January 31, 2017
Retinal venous blood carbon monoxide response to bright light in male pigs: A preliminary studyDan A Oren, Magdalena Duda, Katarzyna Kozioł, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 11, 2004
Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant responseGerard Sanacora, Robert M Berman, Angela Cappiello, et al.
JAMA|June 19, 2003
Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depressionJ Douglas Bremner, Meena Vythilingam, Chin K Ng, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 2, 2009
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled studyAllan H Young, Dan A Oren, Adam Lowy, et al.
Biological Psychiatry|April 2, 2002
Monoamine depletion in unmedicated depressed subjectsRobert M Berman, Gerard Sanacora, Amit Anand, et al.
Depression and Anxiety|May 11, 2010
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorderVladimir Coric, Howard H Feldman, Dan A Oren, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The American Journal of Psychiatry|April 2, 2002
An open trial of morning light therapy for treatment of antepartum depressionDan A Oren, Katherine L Wisner, Margaret Spinelli, et al.
Psychopharmacology|September 6, 2006
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidolRaisa Andrezina, Richard C Josiassen, Ronald N Marcus, et al.
The Journal of Clinical Psychiatry|April 21, 2004
Randomized clinical trial of bright light therapy for antepartum depression: preliminary findingsC Neill Epperson, Michael Terman, Jiuan Su Terman, et al.
Journal of Clinical Pharmacology|July 21, 2006
Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjectsAlbert J Azzaro, Chad M Vandenberg, Lawrence F Blob, et al.
Journal of Photochemistry and Photobiology. B, Biology|January 31, 2017
Retinal venous blood carbon monoxide response to bright light in male pigs: A preliminary studyDan A Oren, Magdalena Duda, Katarzyna Kozioł, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 11, 2004
Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant responseGerard Sanacora, Robert M Berman, Angela Cappiello, et al.
JAMA|June 19, 2003
Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depressionJ Douglas Bremner, Meena Vythilingam, Chin K Ng, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 2, 2009
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled studyAllan H Young, Dan A Oren, Adam Lowy, et al.
Biological Psychiatry|April 2, 2002
Monoamine depletion in unmedicated depressed subjectsRobert M Berman, Gerard Sanacora, Amit Anand, et al.
Depression and Anxiety|May 11, 2010
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorderVladimir Coric, Howard H Feldman, Dan A Oren, et al.
Pageof 3